Market Overview:
The global mammalian transient protein expression market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for recombinant proteins and rising prevalence of chronic diseases. In addition, the growing demand for biologics and increasing investments in R&D are also contributing to the growth of this market. On the basis of type, Chinese hamster ovary cells accounted for the largest share in 2017 and is expected to maintain its dominance during the forecast period. This can be attributed to their ability to produce high-quality proteins as well as their low cost compared with other cell lines.
Product Definition:
Mammalian transient protein expression is a technique used to produce proteins in mammalian cells for a short period of time. This technique can be used to study the function of a protein or to produce large quantities of a protein for further study or therapeutic use. The importance of mammalian transient protein expression lies in its ability to quickly and efficiently produce proteins in mammalian cells.
Chinese Hamster Ovary Cells:
The Chinese hamster ovary (CHO) cells, it's usage and growth factor in mammalian transient protein expression market size was valued at USD 8.0 million in 2015 and is expected to grow at a CAGR of XX% over the forecast period.
Human Embryonic Kidney Cells:
Human embryonic kidney cells (hEK) are a source of non-pluripotent stem cells that can be utilized for the generation of all germ layers in the early embryo. hEK cell lines have been used as a tool to study human developmental biology and to provide an easy method for transiently transfecting genes into these cells.
Application Insights:
The bio production segment dominated the market in 2017 and is expected to witness a CAGR of XX% from 2018 to 2030. The growth can be attributed to the increasing demand for mammalian transient protein expression systems that are used for producing proteins such as insulin, growth factors, antibodies and anticoagulants.
Transiently expressed human proteins can also be used for producing biologics (i.e., therapeutic proteins) using non-human transgenic animals or humans as hosts which have been referred to as chimeric mice or humans respectively. This application segment is anticipated to witness significant expansion during the forecast period owing to rising applications of mammalian transient protein expression systems in research studies pertainingto infectious diseases, oncology, autoimmune disease models along with other disorders affecting humans such as diabetes mellitus type 2 and neurodegenerative disorders among others which require highly purified human recombinant products produced by Chinese hamster ovary cells (CHO).
Regional Analysis:
North America dominated the global market in 2017. This is due to the presence of a large number of research facilities and universities involved in transient protein expression technology. Moreover, increasing demand for products derived from Chinese hamster ovary (CHO) cells has resulted in an increased adoption of this technique by researchers working with cell lines native to other species. The region will retain its dominance throughout the forecast period owing to constant technological advancements pertaining to transgene delivery and stable protein production from different sources.
Asia Pacific is expected to grow at a lucrative rate during the same period owing rising awareness about emerging technologies, availability of raw materials used for manufacturing proteins as well as low cost labor force across countries such as China and India. Furthermore, government funding aimed at promoting basic research activities within this region has also contributed significantly towards growth within Asia Pacific mammalian transient protein expression market segment over past few years (2010–2016).
Growth Factors:
- Increasing demand for biologics and biosimilars
- Growing number of research institutes and contract research organizations (CROs)
- Rising prevalence of chronic diseases
- Technological advancements in transient protein expression platforms
- Growing investments by pharmaceutical and biotechnology companies
Scope Of The Report
Report Attributes
Report Details
Report Title
Mammalian Transient Protein Expression Market Research Report
By Type
Chinese Hamster Ovary Cells, Human Embryonic Kidney Cells, Others
By Application
Bio Production, Functional Cell Based Assays, Academic Research, Others
By Companies
Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc, Mirus Bio LLC, Bio-Rad Laboratories Inc., Qiagen N.V., HiMedia Laboratories, Promega Corporation, Sino Biological Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Mammalian Transient Protein Expression Market Report Segments:
The global Mammalian Transient Protein Expression market is segmented on the basis of:
Types
Chinese Hamster Ovary Cells, Human Embryonic Kidney Cells, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Bio Production, Functional Cell Based Assays, Academic Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck KgaA
- Thermo Fisher Scientific
- Agilent Technologies Inc.
- Lonza, Mirus Bio Inc.
- Takara Bio Inc
- Mirus Bio LLC
- Bio-Rad Laboratories Inc.
- Qiagen N.V.
- HiMedia Laboratories
- Promega Corporation
- Sino Biological Inc.
Highlights of The Mammalian Transient Protein Expression Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chinese Hamster Ovary Cells
- Human Embryonic Kidney Cells
- Others
- By Application:
- Bio Production
- Functional Cell Based Assays
- Academic Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mammalian Transient Protein Expression Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mammalian transient protein expression is the process by which a particular gene is turned on or off in response to external stimuli.
Some of the major companies in the mammalian transient protein expression market are Merck KgaA, Thermo Fisher Scientific, Agilent Technologies Inc., Lonza, Mirus Bio Inc., Takara Bio Inc, Mirus Bio LLC, Bio-Rad Laboratories Inc., Qiagen N.V., HiMedia Laboratories, Promega Corporation, Sino Biological Inc..
The mammalian transient protein expression market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Mammalian Transient Protein Expression Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Mammalian Transient Protein Expression Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Mammalian Transient Protein Expression Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Mammalian Transient Protein Expression Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Mammalian Transient Protein Expression Market Size & Forecast, 2018-2028
4.5.1 Mammalian Transient Protein Expression Market Size and Y-o-Y Growth
4.5.2 Mammalian Transient Protein Expression Market Absolute $ Opportunity
Chapter 5 Global Mammalian Transient Protein Expression Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Mammalian Transient Protein Expression Market Size Forecast by Type
5.2.1 Chinese Hamster Ovary Cells
5.2.2 Human Embryonic Kidney Cells
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Mammalian Transient Protein Expression Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Mammalian Transient Protein Expression Market Size Forecast by Applications
6.2.1 Bio Production
6.2.2 Functional Cell Based Assays
6.2.3 Academic Research
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Mammalian Transient Protein Expression Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Mammalian Transient Protein Expression Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Mammalian Transient Protein Expression Analysis and Forecast
9.1 Introduction
9.2 North America Mammalian Transient Protein Expression Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Mammalian Transient Protein Expression Market Size Forecast by Type
9.6.1 Chinese Hamster Ovary Cells
9.6.2 Human Embryonic Kidney Cells
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Mammalian Transient Protein Expression Market Size Forecast by Applications
9.10.1 Bio Production
9.10.2 Functional Cell Based Assays
9.10.3 Academic Research
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Mammalian Transient Protein Expression Analysis and Forecast
10.1 Introduction
10.2 Europe Mammalian Transient Protein Expression Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Mammalian Transient Protein Expression Market Size Forecast by Type
10.6.1 Chinese Hamster Ovary Cells
10.6.2 Human Embryonic Kidney Cells
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Mammalian Transient Protein Expression Market Size Forecast by Applications
10.10.1 Bio Production
10.10.2 Functional Cell Based Assays
10.10.3 Academic Research
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Mammalian Transient Protein Expression Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Mammalian Transient Protein Expression Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Mammalian Transient Protein Expression Market Size Forecast by Type
11.6.1 Chinese Hamster Ovary Cells
11.6.2 Human Embryonic Kidney Cells
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Mammalian Transient Protein Expression Market Size Forecast by Applications
11.10.1 Bio Production
11.10.2 Functional Cell Based Assays
11.10.3 Academic Research
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Mammalian Transient Protein Expression Analysis and Forecast
12.1 Introduction
12.2 Latin America Mammalian Transient Protein Expression Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Mammalian Transient Protein Expression Market Size Forecast by Type
12.6.1 Chinese Hamster Ovary Cells
12.6.2 Human Embryonic Kidney Cells
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Mammalian Transient Protein Expression Market Size Forecast by Applications
12.10.1 Bio Production
12.10.2 Functional Cell Based Assays
12.10.3 Academic Research
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Mammalian Transient Protein Expression Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Mammalian Transient Protein Expression Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Mammalian Transient Protein Expression Market Size Forecast by Type
13.6.1 Chinese Hamster Ovary Cells
13.6.2 Human Embryonic Kidney Cells
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Mammalian Transient Protein Expression Market Size Forecast by Applications
13.10.1 Bio Production
13.10.2 Functional Cell Based Assays
13.10.3 Academic Research
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Mammalian Transient Protein Expression Market: Competitive Dashboard
14.2 Global Mammalian Transient Protein Expression Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck KgaA
14.3.2 Thermo Fisher Scientific
14.3.3 Agilent Technologies Inc.
14.3.4 Lonza, Mirus Bio Inc.
14.3.5 Takara Bio Inc
14.3.6 Mirus Bio LLC
14.3.7 Bio-Rad Laboratories Inc.
14.3.8 Qiagen N.V.
14.3.9 HiMedia Laboratories
14.3.10 Promega Corporation
14.3.11 Sino Biological Inc.
